Compare DKI & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | DKI | ITOC |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | Hong Kong | China |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 7.0M |
| IPO Year | 2025 | 2024 |
| Metric | DKI | ITOC |
|---|---|---|
| Price | $0.47 | $0.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.4M | 211.4K |
| Earning Date | 01-30-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,078,798.00 | $305,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.25 | N/A |
| 52 Week Low | $0.30 | $0.32 |
| 52 Week High | $15.00 | $32.00 |
| Indicator | DKI | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 30.22 |
| Support Level | $0.55 | $0.41 |
| Resistance Level | $0.66 | $0.49 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 12.23 | 37.65 |
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.